These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 37583930)

  • 21. Clinical-radiomics nomogram for identifying HER2 status in patients with breast cancer: A multicenter study.
    Fang C; Zhang J; Li J; Shang H; Li K; Jiao T; Yin D; Li F; Cui Y; Zeng Q
    Front Oncol; 2022; 12():922185. PubMed ID: 36158700
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Invasive ductal breast cancer: preoperative predict Ki-67 index based on radiomics of ADC maps.
    Zhang Y; Zhu Y; Zhang K; Liu Y; Cui J; Tao J; Wang Y; Wang S
    Radiol Med; 2020 Feb; 125(2):109-116. PubMed ID: 31696388
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic value of breast cancer subtypes, Ki-67 proliferation index, age, and pathologic tumor characteristics on breast cancer survival in Caucasian women.
    Ferguson NL; Bell J; Heidel R; Lee S; Vanmeter S; Duncan L; Munsey B; Panella T; Orucevic A
    Breast J; 2013; 19(1):22-30. PubMed ID: 23240985
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic performance of ultrasound-based artificial intelligence for predicting key molecular markers in breast cancer: A systematic review and meta-analysis.
    Fu Y; Zhou J; Li J
    PLoS One; 2024; 19(5):e0303669. PubMed ID: 38820391
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The regrouping of Luminal B (HER2 negative), a better discriminator of outcome and recurrence score.
    Yang ZJ; Liu YX; Huang Y; Chen ZJ; Zhang HZ; Yu Y; Wang X; Cao XC
    Cancer Med; 2023 Feb; 12(3):2493-2504. PubMed ID: 35909232
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Mathematical Model to Predict Diagnostic Periods for Secondary Distant Metastases in Patients with ER/PR/HER2/Ki-67 Subtypes of Breast Cancer.
    Tyuryumina EY; Neznanov AA; Turumin JL
    Cancers (Basel); 2020 Aug; 12(9):. PubMed ID: 32825078
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prediction of Ki-67 of Invasive Ductal Breast Cancer Based on Ultrasound Radiomics Nomogram.
    Zhu Y; Dou Y; Qin L; Wang H; Wen Z
    J Ultrasound Med; 2023 Feb; 42(3):649-664. PubMed ID: 35851691
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development and validation of an ultrasound-based radiomics nomogram for predicting the luminal from non-luminal type in patients with breast carcinoma.
    Wu J; Ge L; Jin Y; Wang Y; Hu L; Xu D; Wang Z
    Front Oncol; 2022; 12():993466. PubMed ID: 36530981
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Feasibility analysis of predicting expression of estrogen receptor in breast cancer based on radiomics].
    Liu T; Li J; Hu Y; Yu J; Guo Y; Wang Y; Chang C
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2017 Aug; 34(4):597-601. PubMed ID: 29745558
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mammography-based radiomics for predicting the risk of breast cancer recurrence: a multicenter study.
    Mao N; Yin P; Zhang H; Zhang K; Song X; Xing D; Chu T
    Br J Radiol; 2021 Nov; 94(1127):20210348. PubMed ID: 34520235
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A nomogram combined with radiomics features, albuminuria, and metabolic syndrome to predict the risk of myometrial invasion of bladder cancer.
    Zhou Q; Zhang Z; Ang X; Zhang H; Ouyang J
    Transl Cancer Res; 2021 Jul; 10(7):3177-3191. PubMed ID: 35116625
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development and validation of a clinicoradiomic nomogram to assess the HER2 status of patients with invasive ductal carcinoma.
    Xu A; Chu X; Zhang S; Zheng J; Shi D; Lv S; Li F; Weng X
    BMC Cancer; 2022 Aug; 22(1):872. PubMed ID: 35945526
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DCE-MRI Radiomics Analysis in Differentiating Luminal A and Luminal B Breast Cancer Molecular Subtypes.
    Lafcı O; Celepli P; Seher Öztekin P; Koşar PN
    Acad Radiol; 2023 Jan; 30(1):22-29. PubMed ID: 35595629
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An MRI-based Radiomics Classifier for Preoperative Prediction of Ki-67 Status in Breast Cancer.
    Liang C; Cheng Z; Huang Y; He L; Chen X; Ma Z; Huang X; Liang C; Liu Z
    Acad Radiol; 2018 Sep; 25(9):1111-1117. PubMed ID: 29428211
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Machine learning on MRI radiomic features: identification of molecular subtype alteration in breast cancer after neoadjuvant therapy.
    Liu HQ; Lin SY; Song YD; Mai SY; Yang YD; Chen K; Wu Z; Zhao HY
    Eur Radiol; 2023 Apr; 33(4):2965-2974. PubMed ID: 36418622
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Radiomics Signatures Based on Multiparametric MRI for the Preoperative Prediction of the HER2 Status of Patients with Breast Cancer.
    Zhou J; Tan H; Li W; Liu Z; Wu Y; Bai Y; Fu F; Jia X; Feng A; Liu H; Wang M
    Acad Radiol; 2021 Oct; 28(10):1352-1360. PubMed ID: 32709582
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radiomics of Spinal Metastases Originating From Primary Nonsmall Cell Lung Cancer or Breast Cancer and Ability to Predict Epidermal Growth Factor Receptor Mutation/Ki-67 Levels.
    Niu S; Zhang H; Wang X; Jiang W
    J Comput Assist Tomogr; 2023 Jul-Aug 01; 47(4):643-649. PubMed ID: 37380152
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preoperative prediction of axillary lymph node metastasis in patients with breast cancer based on radiomics of gray-scale ultrasonography.
    Zhou WJ; Zhang YD; Kong WT; Zhang CX; Zhang B
    Gland Surg; 2021 Jun; 10(6):1989-2001. PubMed ID: 34268083
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Breast cancer molecular subtypes and receptor status among women at Potchefstroom Hospital: a cross-sectional study.
    Kakudji BK; Mwila PK; Burger JR; du Plessis JM; Naidu K
    Pan Afr Med J; 2021; 38():85. PubMed ID: 33889251
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Real-world data on breast pathologic complete response and disease-free survival after neoadjuvant chemotherapy for hormone receptor-positive, human epidermal growth factor receptor-2-negative breast cancer: a multicenter, retrospective study in China.
    Guan D; Jie Q; Wu Y; Xu Y; Hong W; Meng X
    World J Surg Oncol; 2022 Sep; 20(1):326. PubMed ID: 36175898
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.